Skip to main content
Mingyue Optical Lens Co.,Ltd. logo

Mingyue Optical Lens Co.,Ltd. — Investor Relations & Filings

Ticker · 301101 ISIN · CNE1000054R1 Shenzhen Stock Exchange Manufacturing
Filings indexed 482 across all filing types
Latest filing 2024-04-22 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301101

About Mingyue Optical Lens Co.,Ltd.

https://www.mingyue.com

Mingyue Optical Lens Co.,Ltd. focuses on the research, development, and manufacturing of precision optical lenses. The product range includes high-refractive-index resin lenses, progressive multifocal designs, and specialized solutions such as blue light filtering and photochromic lenses. The company operates an integrated production model that spans from raw material formulation to final lens coating and finishing. Key technical features include advanced anti-reflective treatments and durable surface coatings intended to optimize visual performance. A significant portion of its portfolio is dedicated to myopia management and corrective vision solutions. The company provides technical support and customized lens products to a broad network of retailers and distributors, emphasizing innovation in lens materials and optical design to address complex refractive requirements.

Recent filings

Filing Released Lang Actions
2023年度募集资金存放与使用情况专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2023年度募集资金存放与使用情况专项报告" which translates to "2023 Annual Report on the Deposit and Use of Raised Funds." It details the amount of funds raised, their deposit, usage, and management according to regulatory guidelines from the Shenzhen Stock Exchange and China Securities Regulatory Commission. It includes detailed financial figures on fundraising, usage, bank accounts, and investment projects. The document is a comprehensive report on the use of capital raised by the company, not merely an announcement or a brief summary. It is not an earnings release, call transcript, or management change announcement. It is a specialized report on capital usage and fundraising compliance, which fits best under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed financial data and regulatory compliance information about fundraising and capital usage, not just a notice or announcement. Therefore, the most appropriate classification is CAP.
2024-04-22 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by the company 明月镜片股份有限公司. It references a new accounting standard issued by the Ministry of Finance of China (财政部) and explains the nature and impact of the accounting policy change. The document explicitly states that the change does not require board or shareholder approval and does not materially affect financial statements. The document is short (1177 characters) and serves as a formal disclosure of the accounting policy change rather than a full financial report or audit report. It is not an annual or interim report, nor an audit report, but a regulatory announcement about accounting policy changes. Therefore, it fits best under Regulatory Filings (RNS).
2024-04-22 Chinese
募集资金管理办法
Regulatory Filings Classification · 95% confidence The document is titled '募集资金管理办法' which translates to 'Fundraising Capital Management Measures' and details the management, use, supervision, and regulatory compliance related to the company's raised funds. It references relevant laws, stock exchange rules, and internal company articles. The content is a detailed policy or procedural document about how the company manages and uses funds raised from investors, including rules on storage, usage, changes, and oversight. It does not contain financial statements, earnings data, voting results, or executive changes. It is not a report of financial results or an announcement but a governance or regulatory compliance document related to capital management. This fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory or compliance documents that do not fit other specific categories.
2024-04-22 Chinese
关联交易管理办法
Governance Information Classification · 95% confidence The document is titled "关联交易管理办法" which translates to "Related Party Transaction Management Measures". It is a detailed internal policy document outlining the principles, definitions, management, approval procedures, pricing, disclosure, and other governance aspects related to related party transactions for 明月镜片股份有限公司. The content is regulatory and governance-focused, detailing how related party transactions should be handled, approved, and disclosed, including roles of board members, independent directors, and shareholders. It does not contain financial statements, audit opinions, earnings data, or meeting results. It is not an announcement or a brief summary but a comprehensive governance policy document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-04-22 Chinese
关于自主变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 明月镜片股份有限公司 regarding a change in accounting policy related to inventory cost calculation methods. It details the reasons for the change, the effective date, and the impact on financial statements. The document includes approvals from the board and audit committee but does not contain actual financial statements or detailed financial data. It is a formal disclosure about an accounting policy change rather than a full financial report or audit report. The document length is 2217 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-04-22 Chinese
关于公司及子公司2024年度向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's and its subsidiaries' application for a comprehensive credit facility from banks for the year 2024. It details the approval by the board of directors and the need for shareholder approval. There is no financial report, earnings data, or detailed financial statements included. The document is short (713 characters) and serves as a formal announcement of financing activity rather than a detailed report. Therefore, it fits best under Capital/Financing Update (CAP).
2024-04-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.